Literature DB >> 3119453

Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B.

H P Dienes1, T Hütteroth, G Hess, S C Meuer.   

Abstract

The present knowledge of the inflammatory reaction occurring in situ during hepatitis B favors a T cell-dependent MHC-restricted immune response. However, the reports in the literature are primarily based on the application of monoclonal antibodies directed at different lymphocyte subsets which discern only lymphocytic phenotypes and do not reflect the actual situation adequately. Therefore, we investigated the liver biopsies of patients with hepatitis B (28 patients) and non-A, non-B (21 patients) by immunoelectron microscopy with monoclonal antibodies directed at lymphocyte subtypes (pan-B, pan-T, T8, T4 and NKH1) and at activation epitopes (IL-2 receptor, TA1 and T11/3) as well, in order to determine the phenotype in association with the activation status of the lymphocytes that are in close contact with hepatocytes; thus, establishing an effector-target cell relationship on the ultrastructural level. We were able to confirm the central role of T8 lymphocytes being the predominant type of lymphocytes in close contact with liver cells in the space of Disse. A certain percentage of these cells expressed "activation" markers as IL-2 receptor, TA1 and T11/3. In acute hepatitis, the NK lymphocytes made up a fifth of all lymphocytes, whereas their number dropped below 10% in the chronic stage. There was a vague correlation between the inflammatory activity of the disease and the expression of HLA antigens (both classes I and II) on inflammatory cells and also on hepatocytes. The results did not show significant differences between hepatitis B and non-A, non-B.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119453     DOI: 10.1002/hep.1840070623

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

Review 1.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Immunoelectron microscopic observations on Leu-7 positive cells in virus-related chronic liver diseases.

Authors:  H Himeno; H Enzan; T Saibara; S Onishi; Y Yamamoto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.

Authors:  K Nishioji; T Okanoue; Y Itoh; S Narumi; M Sakamoto; H Nakamura; A Morita; K Kashima
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders.

Authors:  M Hagihara; T Shimura; K Takebe; B Munkhbat; K Hosoi; T Kagawa; N Watanabe; S Matsuzaki; K Yamamoto; K Sato; K Tsuji
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

5.  Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha.

Authors:  D H Van Thiel; X Zhang; N Baddour; H I Wright; L Friedlander; J S Gavaler
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

6.  Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.

Authors:  P M Yang; L H Hwang; M Y Lai; W L Huang; Y D Chu; W K Chi; B L Chiang; J H Kao; P J Chen; D S Chen
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C.

Authors:  H Hanada; K Hino; K Fujii; M Okazaki; K Okita
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

8.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

10.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.